S100 is a broad subfamily of low-molecular weight calcium-binding proteins (9–14 kDa) with
structural similarity and functional discrepancy. It is required for inflammation and cellular …

Rheumatoid arthritis (RA) is a systemic autoimmune disease manifested by chronic joint
inflammation leading to severe disability and premature mortality. With a global prevalence …

Rheumatoid arthritis (RA) is a chronic inflammatory disease that eventually leads to
disability. Inflammatory cell infiltration, severe joint breaking and systemic bone loss are the …

The key role of pro-inflammatory cytokines in the pathogenesis of rheumatoid arthritis (RA)
and psoriatic arthritis (PsA) is strongly supported by the observation that their blockage is …

The past decade has seen a growing appreciation for the role of the innate immune
response in mediating repair and biomaterial directed tissue regeneration. The long-held …

Introduction The current drug therapies for treating rheumatoid arthritis (RA) include
nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, or biological …

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that is characterized by
synovial inflammation, cellular infiltration in joints which leads to progressive joint …

Rheumatoid arthritis (RA) is a serious disorder of the joints affecting 1 or 2% of the
population aged between 20 and 50 years worldwide. RA is the foremost cause of disability …

Endocrine disruptors (EDs) are chemical substances capable of affecting endocrine system
functioning and interfering with organ morphogenesis and physiological functions. The …

Rheumatoid Arthritis (RA) is a chronic autoimmune disease associated with inflammation
and joint remodeling. Adenosine deaminase (ADA), a risk factor in RA, degrades adenosine …